236 related articles for article (PubMed ID: 30791593)
1. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416117
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
5. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives.
Logashenko EB; Salomatina OV; Markov AV; Korchagina DV; Salakhutdinov NF; Tolstikov GA; Vlassov VV; Zenkova MA
Chembiochem; 2011 Mar; 12(5):784-94. PubMed ID: 21328513
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.
Li Y; Feng L; Song ZF; Li HB; Huai QY
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861280
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based Derivatives.
Moustafa GO; Shalaby A; Naglah AM; Mounier MM; El-Sayed H; Anwar MM; Nossier ES
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361728
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.
Xu B; Wu GR; Zhang XY; Yan MM; Zhao R; Xue NN; Fang K; Wang H; Chen M; Guo WB; Wang PL; Lei HM
Molecules; 2017 Jun; 22(6):. PubMed ID: 28574470
[TBL] [Abstract][Full Text] [Related]
14. Novel 3'-Substituted-1',2',4'-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their
Markov AV; Sen'kova AV; Popadyuk II; Salomatina OV; Logashenko EB; Komarova NI; Ilyina AA; Salakhutdinov NF; Zenkova MA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429154
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
Jin L; Huang R; Huang X; Zhang B; Ji M; Wang H
Bioorg Med Chem; 2018 May; 26(8):1759-1775. PubMed ID: 29486954
[TBL] [Abstract][Full Text] [Related]
16. Design, Preparation and Studies Regarding Cytotoxic Properties of Glycyrrhetinic Acid Derivatives.
Zheng QX; Wang R; Xu Y; He CX; Zhao CY; Wang ZF; Zhang R; Dehaen W; Li HJ; Huai QY
Biol Pharm Bull; 2020; 43(1):102-109. PubMed ID: 31902913
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
18. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
Liu D; Song D; Guo G; Wang R; Lv J; Jing Y; Zhao L
Bioorg Med Chem; 2007 Aug; 15(16):5432-9. PubMed ID: 17566745
[TBL] [Abstract][Full Text] [Related]
19. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors.
Yan TL; Bai LF; Zhu HL; Zhang WM; Lv PC
ChemMedChem; 2017 Jul; 12(13):1087-1096. PubMed ID: 28599090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]